Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) Operating Expenses: 2023-2025

Historic Operating Expenses for Zenas BioPharma (ZBIO) over the last 2 years, with Sep 2025 value amounting to $52.6 million.

  • Zenas BioPharma's Operating Expenses rose 28.29% to $52.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $215.7 million, marking a year-over-year increase of 62.13%. This contributed to the annual value of $168.9 million for FY2024, which is 93.80% up from last year.
  • Latest data reveals that Zenas BioPharma reported Operating Expenses of $52.6 million as of Q3 2025, which was down 4.68% from $55.2 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Operating Expenses ranged from a high of $60.6 million in Q4 2024 and a low of $14.4 million during Q3 2023.
  • For the 3-year period, Zenas BioPharma's Operating Expenses averaged around $40.3 million, with its median value being $41.0 million (2024).
  • Data for Zenas BioPharma's Operating Expenses shows a peak YoY surged of 185.09% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Zenas BioPharma's Operating Expenses stood at $24.8 million in 2023, then surged by 144.65% to $60.6 million in 2024, then rose by 28.29% to $52.6 million in 2025.
  • Its last three reported values are $52.6 million in Q3 2025, $55.2 million for Q2 2025, and $47.3 million during Q1 2025.